Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022

SELL
$126.46 - $235.05 $115,710 - $215,070
-915 Closed
0 $0
Q4 2021

Feb 04, 2022

SELL
$225.82 - $368.51 $31,163 - $50,854
-138 Reduced 13.11%
915 $232,000
Q3 2021

Oct 27, 2021

SELL
$221.9 - $484.47 $23,965 - $52,322
-108 Reduced 9.3%
1,053 $405,000
Q2 2021

Aug 05, 2021

BUY
$129.91 - $234.98 $150,825 - $272,811
1,161 New
1,161 $273,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bank Hapoalim Bm Portfolio

Follow Bank Hapoalim Bm and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.